Loading company…
OxStem is an Oxford, UK company developing in-situ cell programming therapies.
OxStem is based in Oxford, UK and was founded in 2013. The firm develops in-situ cell programming therapies to treat dementia, heart failure, macular degeneration, diabetes and oncology. The company is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in